Showing 1 - 20 results of 32 for search 'Heinz-Peter Schultheiss', query time: 0.05s Refine Results
  1. 1
    Viral myocarditis

    Viral myocarditis by Uwe Kühl, Heinz-Peter Schultheiss

    Published 2014-09-01
    Get full text
    Article
  2. 2
    Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

    Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome by Caroline Schmidt-Lucke, Heinz-Peter Schultheiss

    Published 2007-05-01
    Get full text
    Article
  3. 3
    Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment

    Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment by Felicitas Escher, Carsten Tschoepe, Dirk Lassner, Heinz-Peter Schultheiss

    Published 2015-12-01
    Get full text
    Article
  4. 4
    How to perform an endomyocardial biopsy?

    How to perform an endomyocardial biopsy? by Carsten Tschöpe, Behrouz Kherad, Heinz-peter Schultheiss, Carsten Tschöpe, Carsten Tschöpe

    Published 2015-09-01
    Get full text
    Article
  5. 5
    Viral Myocarditis—From Pathophysiology to Treatment

    Viral Myocarditis—From Pathophysiology to Treatment by Heinz-Peter Schultheiss, Christian Baumeier, Ganna Aleshcheva, C.-Thomas Bock, Felicitas Escher

    Published 2021-11-01
    Get full text
    Article
  6. 6
    Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy

    Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy by Christine S. Siegismund, Maria Rohde, Uwe Kühl, Felicitas Escher, Heinz Peter Schultheiss, Dirk Lassner

    Published 2016-08-01
    Get full text
    Article
  7. 7
    Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches

    Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches by Christian Baumeier, Dominik Harms, Ganna Aleshcheva, Ulrich Gross, Felicitas Escher, Heinz-Peter Schultheiss

    Published 2023-07-01
    Get full text
    Article
  8. 8
    MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy

    MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy by Ganna Aleshcheva, Christian Baumeier, Dominik Harms, C.‐Thomas Bock, Felicitas Escher, Heinz‐Peter Schultheiss

    Published 2023-12-01
    Get full text
    Article
  9. 9
    Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial

    Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial by Heinz-Peter Schultheiss, Claus-Thomas Bock, Ganna Aleshcheva, Christian Baumeier, Wolfgang Poller, Felicitas Escher

    Published 2022-02-01
    Get full text
    Article
  10. 10
    Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure

    Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure by Heiko Pietsch, Felicitas Escher, Ganna Aleshcheva, Dirk Lassner, Claus-Thomas Bock, Heinz-Peter Schultheiss

    Published 2020-12-01
    Get full text
    Article
  11. 11
    Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients

    Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients by Heinz-Peter Schultheiss, Thomas Bock, Heiko Pietsch, Ganna Aleshcheva, Christian Baumeier, Friedrich Fruhwald, Felicitas Escher

    Published 2021-04-01
    Get full text
    Article
  12. 12
    Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection

    Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection by Heiko Pietsch, Felicitas Escher, Ganna Aleshcheva, Christian Baumeier, Lars Morawietz, Albrecht Elsaesser, Heinz-Peter Schultheiss

    Published 2021-01-01
    Get full text
    Article
  13. 13
    CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5

    CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5 by Dirk Lassner, Christine S. Siegismund, Uwe Kühl, Maria Rohde, Andrea Stroux, Felicitas Escher, Heinz-Peter Schultheiss

    Published 2018-09-01
    Get full text
    Article
  14. 14
    Genetic deficiency in neprilysin or its pharmacological inhibition initiate excessive stress-induced alcohol consumption in mice.

    Genetic deficiency in neprilysin or its pharmacological inhibition initiate excessive stress-induced alcohol consumption in mice. by Björn Maul, Matthias Becker, Florian Gembardt, Axel Becker, Heinz-Peter Schultheiss, Wolf-Eberhard Siems, Thomas Walther

    Published 2012-01-01
    Get full text
    Article
  15. 15
    Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts

    Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts by Fatih Yergöz, Julian Friebel, Nicolle Kränkel, Ursula Rauch-Kroehnert, Heinz-Peter Schultheiss, Ulf Landmesser, Andrea Dörner

    Published 2021-08-01
    Get full text
    Article
  16. 16
    Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.

    Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. by Caroline Schmidt-Lucke, Stephan Fichtlscherer, Alexandra Aicher, Carsten Tschöpe, Heinz-Peter Schultheiss, Andreas M Zeiher, Stefanie Dimmeler

    Published 2010-11-01
    Get full text
    Article
  17. 17
    Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells

    Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells by Thomas Zobel, C.-Thomas Bock, Uwe Kühl, Maria Rohde, Dirk Lassner, Heinz-Peter Schultheiss, Caroline Schmidt-Lucke

    Published 2019-03-01
    Get full text
    Article
  18. 18
    High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy

    High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy by Felicitas Escher, Uwe Kühl, Dirk Lassner, Andrea Stroux, Ulrich Gross, Dirk Westermann, Burkert Pieske, Wolfgang Poller, Heinz‐Peter Schultheiss

    Published 2017-08-01
    Get full text
    Article
  19. 19
    Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy

    Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy by Felicitas Escher, Ganna Aleshcheva, Heiko Pietsch, Christian Baumeier, Ulrich M. Gross, Benedikt Norbert Schrage, Dirk Westermann, Claus-Thomas Bock, Heinz-Peter Schultheiss

    Published 2021-12-01
    Get full text
    Article
  20. 20
    Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis

    Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis by Wolfgang Poller, MD, Carsten Skurk, MD, Felicitas Escher, MD, Costantina Manes, MD, Thomas Elgeti, MD, Heinz-Peter Schultheiss, MD, Matthias Taupitz, MD, Ulf Landmesser, MD

    Published 2019-10-01
    Get full text
    Article

Search Tools: